GlassScriptPhysician profile
Scott Peters
NPI 1134512171
$4,510.72
in general payments reported to CMS, 2019-2025
7 companies · $3,794 in 2025
The $3,794 reported for 2025 was more than what 95% of Oral and Maxillofacial Pathology providers received nationally (typical 2025 total: $90.97).
See the full distribution for Oral and Maxillofacial Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $93.15 · 2023: $624 · 2025: $3,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,430 · Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,430.18 |
| Food and Beverage | $987.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,631.24 | 2023-2025 | Trumatch |
| Stryker Corporation | $249.39 | 2022-2023 | Na |
| Glaxosmithkline, LLC. | $240.21 | 2023-2025 | Ojjaara |
| Janssen Biotech, INC. | $124.99 | 2025 | Rybrevant, Carvykti |
| Seagen INC. | $115.62 | 2023 | Adcetris |
| Kls-Martin L.P. | $114.27 | 2023 | |
| Biohorizons Implant Systems INC. | $35.00 | 2023 | Biohorizons |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.